NeoMatrix Therapeutics, Inc. (NMT) was founded by Richard A. Clark, M.D., Professor of Dermatology, Biomedical Engineering, and Medicine at Stony Brook University. After years of investigating why wounds fail to heal, Dr. Clark and Dr. Lin discovered a cell-survival peptide in the extracellular matrix (ECM) protein fibronectin (FN) that is absent in nonhealing wounds and burns. This peptide, called NMT-cP12, promotes tissue c...
NeoMatrix Therapeutics, Inc. (NMT) was founded by Richard A. Clark, M.D., Professor of Dermatology, Biomedical Engineering, and Medicine at Stony Brook University. After years of investigating why wounds fail to heal, Dr. Clark and Dr. Lin discovered a cell-survival peptide in the extracellular matrix (ECM) protein fibronectin (FN) that is absent in nonhealing wounds and burns. This peptide, called NMT-cP12, promotes tissue cell survival and growth under harsh culture conditions that mimic unfavorable wound conditions.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.